Browse All
Displaying 6 - 6 of 6
Author:Fox, Robert J. Bar-Or, Amit Traboulsee, Anthony Oreja-Guevara, Celia Giovannoni, Gavin Vermersch, Patrick Syed, Sana Li, Ye Vargas, Wendy S. Turner, Timothy J. Wallstroem, Erik Reich, Daniel S.
Session Name:P7: Multiple Sclerosis: Clinical Trials 1
Topic:Multiple Sclerosis
Program Number:P7.004
Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, OH Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, PA The University of British Columbia, Division of Neurology, Vancouver, Canada, BC, Canada Departamento de Neurologia, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain, Spain Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, United Kingdom University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, France Sanofi, Cambridge, United States, MA Sanofi, Bridgewater, United States, MA Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, MD
